Veracyte Inc (NASDAQ:VCYT)

9.86
Data as of Sep 22
 -0.41 / -3.99%
Today’s Change
9.60
Today|||52-Week Range
19.00
-32.00%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$220.7M

Company Description

Veracyte, Inc. is a molecular diagnostics company. The company discovers, develops and commercializes molecular diagnostic solutions that enable physicians to make more informed treatment decisions early. Its first commercial solution is Afirma Thyroid FNA Analysis, which specializes in cytopathology assessment with the afirma gene expression classifier, a genomic test that clarifies inconclusive thyroid nodule results as benign or suspicious for cancer. The company was founded by Bonnie H. Anderson and Doug Dolginow in February 2008 and is headquartered in South San Francisco, CA.

Contact Information

Veracyte, Inc.
7000 Shoreline Court
South San Francisco California 94080
P:(650) 243-6300
Investor Relations:
(650) 380-4413

Employees

Shareholders

Mutual fund holders9.52%
Individual stakeholders65.01%
Other institutional15.30%

Top Executives

Bonnie H. AndersonPresident, Chief Executive Officer & Director
Christopher M. HallChief Operating Officer
Shelly D. GuyerChief Financial Officer & Secretary
Giulia C. KennedyChief Scientific Officer
Richard B. LanmanChief Medical Officer

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.